COVID-19 Pandemic: A Comparative Prediction Using Machine Learning

Coronavirus Disease 2019 or COVID-19 is an infectious disease which is declared as a pandemic by the World Health Organization (WHO) have a noxious effect on the entire human civilization. Each and every day the number of infected people is going higher and higher and so the death toll. Many of country Italy, UK, USA was affected badly, yet since the identification of the first case, after a certain number of days, the scenario of infection rate has been reduced significantly. However, a country like Bangladesh couldn't keep the infection rate down. A number of algorithms have been proposed to forecast the scenario in terms of the number of infection, recovery and death toll. Here, in this work, we present a comprehensive comparison based on Machine Learning to predict the outbreak of COVID-19 in Bangladesh. Among Several Machine Learning algorithms, here we used Polynomial Regression (PR) and Multilayer Perception (MLP) and Long Short Term Memory (LSTM) algorithm and epidemiological model Susceptible, Infected and Recovered (SIR), projected comparative outcomes

Effect of Corpora on Classification of Fake News using Naive Bayes Classifier

At the present world, one of the main sources of the news is an online platform like different websites and social media i.e. Facebook, Twitter, Linkedin, Youtube, Instagram and so on. However, due to the lack of proper knowledge or deliberate activity of some cunning people, fake news is spreading more than ever. People in general, struggling to filter which news to trust and which one to discard. Even the sly people take advantage of the situation by spreading false news and misleading the people. Natural Language Processing, one of the major branch of Machine Learning, the wealth of research is remarkable. However, new challenges underpinning this development. Here in this work, Naive Bayes Classifier, a Bayesian approach of Machine Learning algorithm has applied to identify the fake news. We showed, besides the algorithms, how the wealth of corpora can assist to improve the performance. The dataset collected from an open-source, has been used to classify whether the news is authenticated or not. Initially, we achieved classification accuracy about 87% which is higher than previously reported accuracy and then 92% by the same Naive Bayes Algorithm with enriched corpora

Assay Type Detection Using Advanced Machine Learning Algorithms

The colourimetric analysis has been used in diversified fields for years. This paper provides a unique overview of colourimetric tests from the perspective of computer vision by describing different aspects of a colourimetric test in the context of image processing, followed by an investigation into the development of a colorimetric assay type detection system using advanced machine learning algorithms. To the best of our knowledge, this is the first attempt to define colourimetric assay types from the eyes of a machine and perform any colorimetric test using deep learning. This investigation utilizes the state-of-the-art pre-trained models of Convolutional Neural Network (CNN) to perform the assay type detection of an enzyme-linked immunosorbent assay (ELISA) and lateral flow assay (LFA). The ELISA dataset contains images of both positive and negative samples, prepared for the plasmonic ELISA based TB-antigen specific antibody detection. The LFA dataset contains images of the universal pH indicator paper of eight pH levels. It is noted that the pre-trained models offered 100% accurate visual recognition for the assay type detection. Such detection can assist novice users to initiate a colorimetric test using his/her personal digital devices. The assay type detection can also aid in calibrating an image-based colorimetric classification

iBUST: An intelligent behavioural trust model for securing industrial cyber-physical systems

To meet the demand of the world's largest population, smart manufacturing has accelerated the adoption of smart factories—where autonomous and cooperative instruments across all levels of production and logistics networks are integrated through a Cyber-Physical Production System (CPPS). However, these networks are comprised of various heterogeneous devices with varying computational power and memory capabilities. As a result, many secure communication protocols – that demand considerably high computational power and memory – can not be verbatim employed on these networks, and thereby, leaving them more vulnerable to security threats and attacks over conventional networks. These threats can largely be tackled by employing a Trust Management Model (TMM) by exploiting the behavioural patterns of nodes to identify their trust class. In this context, ML-based models are best suited due to their ability to capture hidden patterns in data, learning and improving the pattern detection accuracy over time to counteract and tackle threats of a dynamic nature, which is absent in most of the conventional models. However, among the existing ML-based solutions in detecting attack patterns, many of them are computationally expensive, require a long training time, and a considerably large amount of training data—which are seldom available. An aid to this is the association rule learning (ARL) paradigm, whose models are computationally inexpensive and do not require a long training time. Therefore, this paper proposes an ARL-based intelligent Behavioural Trust Model (iBUST) for securing the CPPS. For this intelligent TMM, a variant of Frequency Pattern Growth (FP-Growth), called enhanced FP-Growth (EFP-Growth) algorithm is developed by altering the internal data structures for faster execution and by developing a modified exponential decay function (MEDF) to automatically calculate minimum supports for adapting trust evolution characteristics. In addition, a new optimisation model for finding optimum parameter values in the MEDF and an algorithm for transmuting a 1D quantitative feature into a respective categorical feature are developed to facilitate the model. Afterwards, the trust class of an object is identified employing the Naïve Bayes classifier. This proposed model is evaluated on a trust evolution-supported experimental environment along with other compared models taking a benchmark dataset into consideration, where it outperforms its counterparts

ACCU3RATE: A mobile health application rating scale based on user reviews

Background- Over the last decade, mobile health applications (mHealth App) have evolved exponentially to assess and support our health and well-being. Objective- This paper presents an Artificial Intelligence (AI)-enabled mHealth app rating tool, called ACCU3RATE, which takes multidimensional measures such as user star rating, user review and features declared by the developer to generate the rating of an app. However, currently, there is very little conceptual understanding on how user reviews affect app rating from a multi-dimensional perspective. This study applies AI-based text mining technique to develop more comprehensive understanding of user feedback based on several important factors, determining the mHealth app ratings. Method- Based on the literature, six variables were identified that influence the mHealth app rating scale. These factors are user star rating, user text review, user interface (UI) design, functionality, security and privacy, and clinical approval. Natural Language Toolkit package is used for interpreting text and to identify the App users’ sentiment. Additional considerations were accessibility, protection and privacy, UI design for people living with physical disability. Moreover, the details of clinical approval, if exists, were taken from the developer’s statement. Finally, we fused all the inputs using fuzzy logic to calculate the new app rating score. Results and conclusions- ACCU3RATE concentrates on heart related Apps found in the play store and App gallery. The findings indicate the efficacy of the proposed method as opposed to the current device scale. This study has implications for both App developers and consumers who are using mHealth Apps to monitor and track their health. The performance evaluation shows that the proposed mHealth scale has shown excellent reliability as well as internal consistency of the scale, and high inter-rater reliability index. It has also been noticed that the fuzzy based rating scale, as in ACCU3RATE, matches more closely to the rating performed by experts

iWorksafe: Towards Healthy Workplaces During COVID-19 With an Intelligent Phealth App for Industrial Settings

The recent outbreak of the novel Coronavirus Disease (COVID-19) has given rise to diverse health issues due to its high transmission rate and limited treatment options. Almost the whole world, at some point of time, was placed in lock-down in an attempt to stop the spread of the virus, with resulting psychological and economic sequela. As countries start to ease lock-down measures and reopen industries, ensuring a healthy workplace for employees has become imperative. Thus, this paper presents a mobile app-based intelligent portable healthcare (pHealth) tool, called i WorkSafe, to assist industries in detecting possible suspects for COVID-19 infection among their employees who may need primary care. Developed mainly for low-end Android devices, the i WorkSafe app hosts a fuzzy neural network model that integrates data of employees’ health status from the industry’s database, proximity and contact tracing data from the mobile devices, and user-reported COVID-19 self-test data. Using the built-in Bluetooth low energy sensing technology and K Nearest Neighbor and K-means techniques, the app is capable of tracking users’ proximity and trace contact with other employees. Additionally, it uses a logistic regression model to calculate the COVID-19 self-test score and a Bayesian Decision Tree model for checking real-time health condition from an intelligent e-health platform for further clinical attention of the employees. Rolled out in an apparel factory on 12 employees as a test case, the pHealth tool generates an alert to maintain social distancing among employees inside the industry. In addition, the app helps employees to estimate risk with possible COVID-19 infection based on the collected data and found that the score is effective in estimating personal health condition of the app user

Measuring Coverage in MNCH:A Prospective Validation Study in Pakistan and Bangladesh on Measuring Correct Treatment of Childhood Pneumonia

Antibiotic treatment for pneumonia as measured by Demographic and Health Surveys (DHS) and Multiple Indicator Cluster Surveys (MICS) is a key indicator for tracking progress in achieving Millennium Development Goal 4. Concerns about the validity of this indicator led us to perform an evaluation in urban and rural settings in Pakistan and Bangladesh.Caregivers of 950 children under 5 y with pneumonia and 980 with "no pneumonia" were identified in urban and rural settings and allocated for DHS/MICS questions 2 or 4 wk later. Study physicians assigned a diagnosis of pneumonia as reference standard; the predictive ability of DHS/MICS questions and additional measurement tools to identify pneumonia versus non-pneumonia cases was evaluated. Results at both sites showed suboptimal discriminative power, with no difference between 2- or 4-wk recall. Individual patterns of sensitivity and specificity varied substantially across study sites (sensitivity 66.9% and 45.5%, and specificity 68.8% and 69.5%, for DHS in Pakistan and Bangladesh, respectively). Prescribed antibiotics for pneumonia were correctly recalled by about two-thirds of caregivers using DHS questions, increasing to 72% and 82% in Pakistan and Bangladesh, respectively, using a drug chart and detailed enquiry.Monitoring antibiotic treatment of pneumonia is essential for national and global programs. Current (DHS/MICS questions) and proposed new (video and pneumonia score) methods of identifying pneumonia based on maternal recall discriminate poorly between pneumonia and children with cough. Furthermore, these methods have a low yield to identify children who have true pneumonia. Reported antibiotic treatment rates among these children are therefore not a valid proxy indicator of pneumonia treatment rates. These results have important implications for program monitoring and suggest that data in its current format from DHS/MICS surveys should not be used for the purpose of monitoring antibiotic treatment rates in children with pneumonia at the present time